CD163 was selected as the stratifying marker in this study due to its well-established role as a highly specific marker for M2-polarized tumor-associated macrophages, which play pivotal roles in immunosuppression, tumor progression, and metastatic dissemination [16]. The gene discussed is CD163; the disease is neoplasm.